Marty Makary resigned as FDA commissioner amid controversy. But his reforms to drug review times and AI are the agency's biggest modernization in decades.

Marty Makary resigned as FDA commissioner amid controversy. But his reforms to drug review times and AI are the agency's biggest modernization in decades.

Trump administration unwinds ex-FDA chief Makary's tenure as acting head Diamantas revisits drug decisions and puts his signature voucher program in doubt.